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Hemodialyzer reuse: Estimation of area loss from clearance
data. A procedure is described for estimating the loss in effective
membrane area of a dialyzer during repeated reuse. The tech-
nique involves the accurate measurement of dialyzer clearance
both before and after reuse. Either large or small molecule
clearance can be used to estimate the area loss and clearances
can be determined either in vivo or in vitro following the dialysis.
Excellent agreement has been obtained between theoretical
estimates of fiber bundle loss in hollow fiber artificial kidneys
(based on clearance data) and values determined by saline rinse
techniques. It should be possible to extend this theoretical proce-
dure to flat-plate dialyzers for which there is no analogous proce-
dure to fiber bundle loss for determining loss in effective mem-
brane area with repeated reuse. Extension of the procedure to
determine area losses for coil dialyzers is not recommended.
Réutilisation d'hémodialyseur: Evaluation de Ia perte de
surface au moyen des valeurs de clearance. Un procédé d'estima-
tion de la perte de surface efficace de Ia membrane d'un dialyseur
au cours des réutilisations itératives est décrit. La technique
implique Ia determination precise de la clearance du dialyseur
avant et après réutilisation, Les clearances des grosses ou des
petites molecules peuvent être utilisées pour évaluer la perte de
surface. Les clearances peuvent être déterminées soit in vivo soit
Ifl Vitro aprés Ia dialyse. Une excellente concordance a Cté
obtenue entre les evaluations theoriques (fondées sur les valeurs
des clearances) de pertes de faisceaux de fibres dans des reins
artificiels a fibres creuses et les valeurs déterminées par les
techniques de rincage avec du solute sale. II devrait Ctre possible
d'étendre cc procédé théorique aux dialyseurs en plaques pour
lesquels il n'existe pas de procédé analogue a celui utilisé avec
des fibres creuses pour determiner Ia perte de membrane efficace
en fonction de Ia réutilisation. L'extension du procédé aux
dialysuers a bobine nest pas recommandée.
Hemodialyzer reuse by individual patients has been
shown to result in significant savings in money and
time [1]. The Kiil [2], twin-coil [3] and, more recently,
the Dow hollow fiber artificial kidney (HFAK) [4]
have been successfully reused. The number of reuses has
varied depending on the amount of fibrin deposition,
platelet aggregation and other debris that result in the
loss of effective membrane area for dialysis. The extent
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of these deposits in the Ku! dialyzer has generally been
determined by visual examination when the Ku! is
disassembled. However, there is little certainty that
the loss of effective area for dialysis is actually repre-
sented by this qualitative estimate of area loss. On the
contrary, blood-component deposition in the Dow
HFAK is not possible to estimate visually because of
the large number of fibers. Gotch et al [5, 6] have
devised a method of determining volume loss (repro-
ducible to 3%) and demonstrated that it correlated
with whole blood left in the kidney and to changes in
blood flow resistance. They concluded that the method
provides a simple, reliable technique to estimate the
percent of occluded fibers. We have used this technique
to determine fiber bundle loss (FBL) after each dialysis
in which the HFAK is reused and we have arbitrarily
reused the HFAK clinically up to a FBL of 4O%.
In this article, a theoretical method to determine the
loss of effective membrane surface area from clearance
data is presented and is shown to correlate well with
area losses as determined by volume loss measure-
ments. This theoretical procedure is largely of aca-
demic interest in evaluating capillary dialyzer reuse,
since FBL is relatively easy to obtain. However, the
technique should be useful for flat-plate dialyzers to
determine more quantitatively actual loss in effective
membrane area caused by repeated dialyses.
Methods
If M represents the mass transferred in one pass
through a dialyzer, clearance (K) is given by the follow-
ing:
CBI
(I)
where is inlet solute concentration in the blood.
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Under conditions of minimal ultrafiltration where
inlet and outlet blood flows are approximately con-
stant, M is represented as
M = QB(CBI—CBO), (2)
where CB0 is outlet solute concentration in the blood.
Under conditions of countercurrent dialyzer
operation where QD is dialysate flow and CD is
dialysate concentration, M is also given by
M = QD(CDO—CDI). (3)
The mass transferred can be also written in the follow-
ing form:
M = h0A CLM, (4)
where h0 is the overall mass transfer coefficient, A is
effective membrane area and LCLM is the log-mean
driving force and is given by the following:
= (C1—CD0)—(C0—CD1)LM (_'
In j'-B D0Ia'* C'L Bo D1
C and C0 are free solute concen-
related to total concentration as
— C1B (l+p)
—-
Here t represents the volume fraction of free water in
the blood and p is the solute-protein binding coeffi-
cient and represents the ratio of bound solute to free
solute [7].
Equating equations 1, 2 and 4 and with the use of
the remaining equalities, it can be shown that clear-
ance is given by the following:
h0A (1_(l+P)2)QD
—10
K—— B
loA(1—L(l+P)) QB
exp L(l+p)QB
(7)
This expression assumes three factors: 1) counter-
current flow, 2) minimal ultrafiltration and 3) an
incoming dialysate concentration (CD1) of zero.
Rearrangement of equation 7 yields:
+p)K
______________
QD (8
QB
Given the assumptions just described, equation 7 is
the complete expression for whole blood clearance in
terms of flow rates, the binding factor and membrane
dialyzer characteristics.
A rigorous application of this formula requires
knowledge of the solute-protein interactions as well as
the solute-erythrocyte mass transfer kinetics. The
binding factor p can be readily obtained by ultra-
filtration or other procedures. As an example, urea is
essentially unbound in uremics [8] so that p=O.
Furthermore, urea transfer in red blood cells (RBCs)
is very rapid and it can be assumed that this solute is
transferred essentially instantaneously between eryth-
rocytes and plasma. For a hematocrit value of 20%,
assuming that 80% of RBC water is free and that the
plasma water fraction is 0.93, i computes to 0.9.
Hence, in equation 7, t(l +p)=O.9.
On the contrary, for creatinine the transfer out of
the erythrocyte is slow [9] and this results in a venous
(5) RBC-plasma disequilibrium [9, 10]. In this instance it
can be assumed that the erythrocytes are not involved.
Creatinine is also unbound [7] so that i(l+p)=O.74
for a hematocrit value of 20%.
For the purposes of discussion, consider the in vitro
situation where =1.0, p=O and i(l+p)=l.O.
Equation 7 then reduces to the following:
Estimation of fiber loss for HFAK. For an HFAK
containing n0 individual fibers, the h0A term can be
written as follows:
h0A = h0A1n0, (10)
where Af is the mass transfer area of a single fiber
(=2ITrL, where r is the fiber radius and L is fiber
length).
After a single dialysis we have assumed that n1 active
blood-carrying fibers remain; after the first reuse n2
fibers remain; after the second, n3 and so on.
For the case where (1 + p)= 1.0 in vitro, equation 8
can be written as follows:
Q 11 —KI/QD11li0A, h0A1n1 = In i ' (11)'
'.B1/'.1Jj L' — i/'.B1J
where subscript i refers to conditions prevailing during
reuse, i (0, 1, 2, 3, . .
Data have been obtained for regenerated cellulose
(a material which constitutes both Dow HFAK fibers
and cuprophane) which show that protein deposition
ds not appear to affect membrane permeability,
since plasma, human serum albumin and saline
environments give the same h0 value for a nonbinding
solute [7]. On this basis, for nonocciuded fibers we
have assumed that h0A1 is constant for a given set of
where in this case
trations and are
follows [7]:
(6) K=QB (9)
h0A ln= (l_(l+p))
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Table 1. Urea clearance for Dow HFAK reuse
Dialyzer Run Patient
hematocrit
%
Urea
clearanceb
mi/mm
Qo
mi/mm
Q
mi/mm
Dow HFAK Initial use 20 146± 3 228 500
#3, unit A
Dow HFAK
Run 6
(5 reuses)
Initial use
—
22
89± P
148 3
200
205
500
500
#3, unit B
Dow UFAK
Run 9
(S reuses)
Initial use
24
22
103±2
147± 3
155
203
500
500
#3, unit C Run 15
(l4reuses) 26 110±2 191 500
Clearance data were taken about one hour before termination of dialysis.b In vitro data: hematocrit value not relevant for this point.
flow conditions. It can be shown theoretically from the
Graetz analysis [12] that h0 should be independent of
QB for the hollow fiber geometry since entrance effects
are negligible. However, Gotch et al [5, 6] report that
h0 for urea appeared to increase up to a QB of200 ml/
mm and then level off. Nevertheless, there is general
agreement that h0 is independent of QB in the clinical
range.
To compare serial clearance measurements, it is
also necessary to ensure that transmembrane pressures
are identical. This is particularly important for
larger molecules where there may be a convective
contribution to h0Af.
The degree of fiber bundle loss is estimated as
follows:
% fiber loss = (n0—n1) 100. (12)
no
With hOAf constant equations 11 and 12 can be
combined to yield:
(13)
where subscript 0 refers to initial conditions on the
first run and subscript i refers to conditions on reuse i.
It should again be emphasized that this equation
applies only for countercurrent flow where C1 is
zero.
Since the fiber loss is directly proportional to loss of
effective membrane area, equation 13 should be
applicable for estimating the loss in effective area for a
parallel-plate dialyzer. If the clearance data are taken
in vivo, equation 13 should be modified to include
binding and volume exclusion factors as per equation 8.
Results
Fiber loss from urea clearance. Recently, three Dow
HFAK model 3 units were reused 5, 8 and 14 times,
respectively, at the Research Dialysis Unit at this
University. After reuse, FBL was estimated by deter-
mining the remaining volume of fibers by saline rinse.
The experimental conditions and urea clearance data
for these dialyzers are given in Table 1.
Using the data of Table I and the complete expres-
sion for fiber loss in vii'o (derived from equation 8),
the theoretical values of FBL were determined. These
latter values, compared with fiber loss determined by
saline rinse techniques [5], are shown in Table 2. The
data are in good agreement although the theoretical
area loss is consistently slightly less than the measured
FBL.
Fiber loss from creatinine clearance. The potential
problems of creatinine venous-plasma disequilibrium
[9, 10] make this solute less attractive than urea for
determining area loss with reuse. Nevertheless, for
Dialyzer Uses,
N
Measured FBL,0 Theoretical area
loss or FBL,b/,
Dow HFAK
unit A 6 50.3 48.0
Dow HFAK
unit B 9 31.8 31.0
Dow 1-IFAK
unit C 15 42.7 41.0
Table 2. Comparison between theoretical and measured fiber
bundle loss in hollow fiber kidneys
Based on saline rinse, volume loss determinations as per
Gotch et a! 151.
Determined theoretically from urea clearance reduction after
reuse (equation 13).
[1.0— VBVD in F(CB—CD)O1 1
In
L
(YB + VD)QDt LcB— CD)u] I
1.0— VBVD j 1(CB—CD)O1 I'(YB + VD)QBt {(CB— C)jj
% FBL = (13.0—6.6) 100 = 49.2%.
This value is again in good agreement with the saline
rinse value of about 50°,/ for unit A (Table 2).
Discussion
Until cheap, disposable artificial kidneys are prac-
tical for human use, reuse of present standard dialyzers
will continue to be an important goal of many dialysis
units and patients. Recently, the feasibility and
practicality of almost indefinite reuse of the MPS Kiil
(Meltec Limited) has been demonstrated by Shaldon
[11]. However, in order to evaluate effectively new
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unt C care was taken to account for the effect of
ar ifacts and reasonable agreement was obtained be-
tw een FIL determined by saline rinse and urea and
c, 'eatinine clearance data.
Yenus blood samples were immediately spun down
ollowing sampling and mass tranfer rates were based
on the plasma phase. The flow rate and hematocrit
values are given in the third row of data in Table 1
(unit C). The initial and final creatinine clearances
were 126 and 91±2 mI/mm, respectively. This
cQmputes to an FBL of 40% which is in reasonable
agreement with the saline rinse and urea clearance
results for unit C given in Table 2. However, because
of potential artifacts due to disequilibrium, it is
recommended that for the lower molecular weight
solutes, urea rather than creatinine should be used to
evaluate loss of membrane area in reuse.
Fiber loss from vitamin B12 clearance. The overall
mass transfer coefficient times membrane area (h0A)
can be determined directly for vitamin B12 due to its
small membrane diffusivity value. For dual closed-
loop operation in vitro under conditions of minimal
ultrafiltration, it can be shown that
hA QBo - i-QB/QD
(14)
where YB and 1D are loop volumes and subscripts 0
and f refer to initial and final conditions.
Using the formula just given, h0A for YB12 was
determined as 13.0 mI/mm for the Dow 1-IFAK model
3, under standard dialysis operating conditions
(QB 200, QD 500, temperature (T) =37°C). After five
reuses YB12 clearance was determined as 6.6 mI/mm at
Q8 200, QD 500, T=37°C for unit A.
FBL can now be determined directly as follows:
techniques in dialyzer reuse, the investigator must be
able to determine quantitatively the loss in effective
membrane area. Yolume loss determination is an
appropriate method to assess area loss in the case of
HFAK units. Furthermore, the procedure is simple
and does not require extra blood sampling. On the
contrary, for flat-plate dialyzers an analogous proce-
dure based on volume loss is not available for estima-
ting area loss during repeated reuse of the dialyzer.
An analytical procedure based on serial clearance
measurements may provide an adequate alternative to
evaluate this parameter. However, reliable use of this
technique would require demonstration that h0
remains constant in these dialyzers. In flat-plate
dialyzers, thrombus formation could cause unpre-
dictable changes in overall mass transfer resistance.
This would then result in errors in estimating the
overall loss of effective membrane area.
It should also be noted that area losses cannot be
determined for coil dialyzers with any accuracy by the
use of serial clearance data. The reason for this
is that the previously described theoretical analysis
requires negligible ultrafiltration and a constant
h0 value.
The condition of negligible ultrafiltration cannot be
approached closely enough with coil dialyzers because
of the comparatively high blood-side pressure drops
associated with these units. In the second case, possible
variations in the blood channel dimensions of the coil
on repeated reuse make it extremely remote that h0
would remain sufficiently constant, since the latter
index depends directly upon blood channel dimensions.
Another important factor to be borne in mind when
one considers dialyzer reuse is the following. As
effective membrane area is lost to varying degrees
during reuse, some adjustment in time on dialysis
may be necessary to compensate for the area loss, so
that an equivalent dialysis protocol is maintained.
Recently, it was suggested by Babb et al [13] that
the adequacy of dialysis for a given dialyzer-membrane
system could be gauged by the number of square
meter-hours of dialysis (i.e., membrane area by time on
dialysis). it has been more recently shown [14] that
this yardstick may not be strictly applicable, yet it
provides a quantitative and adequate means to
determine the increase in dialysis time necessary to
compensate for area loss. For example, the initial
time on dialysis would be increased by 50% for a 33%
loss in effective dialyzer area and by l00% for a 50%
loss in area, to obtain an approximately equivalent
dialysis. This procedure has been followed in our
reuse experiments.
One could argue that increasing time on dialysis to
compensate for area loss may be somewhat unwise
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since there may be risk of development of a possible
small-molecule deficiency syndrome [15]. The removal
of large molecules ( 1000 mol wt) would remain un-
changed by the maintenance of a constant area-time
product, but small molecule (s 250 mol wt) removal is
certainly increased [13]. Nevertheless, while the relative
importance of middle molecule toxicity and the
relevance of possible deficiency syndromes remain
moot points, we feel it is more sensible to moderately
overdialyze the patient, since it has been shown that
more frequent and longer dialyses reverse neuropathy
[16, 17]. Consequently, we would suggest that area
loss be compensated by increased time on dialysis.
How much area loss can be tolerated with the in-
creased time compensation is a question to be answered
by either the patient or the physician.
Reprint requests to Dr. Peter C. Farrell, Department of
Biological and Process Engineering, The University of New South
Wales, P. 0. Box I, Kensington, New South Wales, Australia.
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